Cascade Prodrug
Cascade prodrug is developing a novel technology that targets and activates a therapeutic prodrug within solid tumors.
Launch date
Employees
Market cap
-
Enterprise valuation
€5—7m (Dealroom.co estimates Apr 2013.)
Eugene Oregon (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | $100k | Debt | |
N/A | $1.3m | Series A | |
N/A | Series B | ||
N/A | $200k | Series B | |
Total Funding | €1.4m |
Related Content
Recent News about Cascade Prodrug
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.